Table 2 Odds ratio and 95 % confidence interval for metabolic syndrome and its components according to total fat and SFA intakes among participants of the Tehran Lipid and Glucose study^a

Total fat < median

Total fat ≥ median

Total fat < median

Total fat ≥ median

Enlarged waist circumference

 Model 1

1

1.35 (1.11-1.65)

1.57 (1.37-1.80)

1.40 (1.16-1.67)

 Model 2

1

1.24 (1.00-1.54)

1.40 (1.17-1.69)

1.30 (1.07-1.57)

 Model 3

1

0.99 (0.71-1.37)

1.26 (0.96-1.66)

1.37 (1.02-1.83)

Low serum HDL cholesterol

 Model 1

1

1.10 (0.91-1.34)

1.07 (0.93-1.22)

1.00 (0.83-1.19)

 Model 2

1

1.01 (0.81-1.25)

0.90 (0.74-1.10)

0.95 (0.78-1.14)

 Model 3

1

0.97 (0.78-1.21)

0.86 (0.71-1.04)

0.91 (0.75-1.11)

Abnormal glucose homeostasis

 Model 1

1

0.94 (0.74-1.19)

1.31 (1.13-1.53)

1.50 (1.23-1.84)

 Model 2

1

0.97 (0.75-1.25)

1.32 (1.07-1.63)

1.38 (1.11-1.70)

 Model 3

1

0.87 (0.67-1.14)

1.22 (0.98-1.52)

1.32 (1.06-1.65)

Elevated blood pressure

 Model 1

1

1.31 (1.04-1.64)

1.29 (1.05-1.60)

1.49 (1.27-1.74)

 Model 2

1

1.29 (1.01-1.65)

1.22 (0.98-1.52)

1.44 (1.17-1.77)

 Model 3

1

1.17 (0.91-1.52)

1.15 (0.91-1.45)

1.32 (1.06-1.64)

High serum triglyceride concentrations

 Model 1

1

1.24 (1.00-1.53)

1.18 (0.97-1.44)

1.73 (1.50-2.00)

 Model 2

1

1.06 (0.84-1.34)

1.10 (0.90-1.35)

1.42 (1.16-1.73)

 Model 3

1

0.99 (0.77-1.27)

1.04 (0.84-1.29)

1.36 (1.10-1.68)

Metabolic syndrome

 Model 1

1

1.16 (0.93-1.45)

1.66 (1.44-1.93)

1.40 (1.15-1.71)

 Model 2

1

1.09 (0.86-1.38)

1.50 (1.23-1.83)

1.29 (1.10-1.59)

 Model 3

1

0.92 (0.70-1.21)

1.39 (1.11-1.74)

1.22 (1.05-1.55)